rs2453051

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_024408.4(NOTCH2):​c.2027-1718T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 152,082 control chromosomes in the GnomAD database, including 2,895 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2895 hom., cov: 32)

Consequence

NOTCH2
NM_024408.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.239

Publications

12 publications found
Variant links:
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
  • acroosteolysis dominant type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome due to a NOTCH2 point mutation
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH2NM_024408.4 linkc.2027-1718T>G intron_variant Intron 12 of 33 ENST00000256646.7 NP_077719.2
NOTCH2NM_001200001.2 linkc.2027-1718T>G intron_variant Intron 12 of 21 NP_001186930.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH2ENST00000256646.7 linkc.2027-1718T>G intron_variant Intron 12 of 33 1 NM_024408.4 ENSP00000256646.2
NOTCH2ENST00000479412.2 linkn.2165-1718T>G intron_variant Intron 11 of 13 1
NOTCH2ENST00000640021.1 linkn.*1151-1718T>G intron_variant Intron 9 of 11 5 ENSP00000492223.1

Frequencies

GnomAD3 genomes
AF:
0.167
AC:
25328
AN:
151964
Hom.:
2884
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.322
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.107
Gnomad ASJ
AF:
0.0833
Gnomad EAS
AF:
0.0319
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.133
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.157
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.167
AC:
25360
AN:
152082
Hom.:
2895
Cov.:
32
AF XY:
0.167
AC XY:
12385
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.322
AC:
13347
AN:
41392
American (AMR)
AF:
0.107
AC:
1631
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0833
AC:
289
AN:
3470
East Asian (EAS)
AF:
0.0316
AC:
164
AN:
5190
South Asian (SAS)
AF:
0.189
AC:
915
AN:
4830
European-Finnish (FIN)
AF:
0.133
AC:
1410
AN:
10580
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.106
AC:
7196
AN:
68002
Other (OTH)
AF:
0.156
AC:
330
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1016
2032
3047
4063
5079
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.142
Hom.:
238
Bravo
AF:
0.169
Asia WGS
AF:
0.164
AC:
571
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
4.6
DANN
Benign
0.62
PhyloP100
-0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2453051; hg19: chr1-120499573; API